Patient leaflet - Lamictal tablets 25 mg
1 What Lamictal is and what it is used for
Lamictal belongs to a group of medicines called anti-epileptics. It is used to treat two conditions - epilepsy and bipolar disorder.
Lamictal treats epilepsy by blocking the signals in the brain that trigger epileptic seizures (fits)
For adults and children aged 13 years and over, Lamictal
can be used on its own or with other medicines, to treat epilepsy. Lamictal can also be used with other medicines to treat the seizures that occur with a condition called Lennox-Gastaut syndrome.
For children aged between 2 and 12 years, Lamictal can
be used with other medicines, to treat those conditions. It can be used on its own to treat a type of epilepsy called typical absence seizures.
Lamictal also treats bipolar disorder
People with bipolar disorder (sometimes called manic depression) have extreme mood swings, with periods of mania (excitement or euphoria) alternating with periods of depression (deep sadness or despair). For adults aged 18 years and over, Lamictal can be used on its own or with other medicines, to prevent the periods of depression that occur in bipolar disorder. It is not yet known how Lamictal works in the brain to have this effect.
2 What you need to know before you take Lamictal
Do not take Lamictal:
if you are allergic (hypersensitive) to lamotrigine or any of
the other ingredients of this medicine (listed in section 6). If this applies to you:
➔ Tell your doctor and don’t take Lamictal.
Warnings and precautions
Take special care with Lamictal
Talk to your doctor or pharmacist before taking Lamictal:
- if you have any kidney problems
if you have ever developed a rash after taking lamotrigine
or other medicines for bipolar disorder or epilepsy
if you experience a rash or sunburn after taking lamotrigine
and having been exposed to sun or artificial light (e.g. solarium). Your doctor will check your treatment and may advise you to avoid sunlight or protect yourself against the sun (e.g. use of a sunscreen and/or to wear protective clothing)
if you have ever developed meningitis after taking
lamotrigine (read the description of these symptoms in section 4 of this leaflet: Rare side effects)
- if you are already taking medicine that contains lamotrigine.
if you have a condition called Brugada syndrome, or other
heart problems. Brugada syndrome is a genetic disease that results in abnormal electrical activity within the heart. ECG abnormalities which may lead to arrhythmias (abnormal heart rhythm) can be triggered by lamotrigine. If any of these applies to you:
➔ Tell your doctor, who may decide to lower the dose or that
Lamictal is not suitable for you.
Important information about potentially life-threatening reactions
A small number of people taking Lamictal get an allergic reaction or potentially life-threatening skin reaction, which may develop into more serious problems if they are not treated. These can include Stevens–Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). You need to know the symptoms to look out for while you are taking Lamictal. These include skin rashes or redness, ulcers in the mouth or throat, sore mouth or
throat, red or swollen eyes, fever, swelling around your face, swollen glands, unexpected bleeding or bruising. ➔ Read the description of these symptoms in section 4 of
this leaflet under ‘Potentially life-threatening reactions: get a doctor’s help straight away’.
The risk of serious skin reactions may be associated with a variant in genes called HLA-B*1502 in people from Asian origin (mainly Han Chinese and Thai). If you have been tested previously and know you are carrying this genetic variant, discuss this with your doctor before taking Lamictal. Haemophagocytic lymphohistiocytosis (HLH)
There have been reports of a rare but very serious immune system reaction, in patients taking lamotrigine. ➔ Contact your doctor or pharmacist immediately if you
experience any of the following symptoms while taking lamotrigine: fever, rash, neurological symptoms (e.g. shaking or tremor, confusional state, disturbances of brain function). Thoughts of harming yourself or suicide
Anti-epileptic medicines are used to treat several conditions, including epilepsy and bipolar disorder. People with bipolar disorder can sometimes have thoughts of harming themselves or committing suicide. If you have bipolar disorder, you may be more likely to think like this:
- when you first start treatment
if you have previously had thoughts about harming yourself
or about suicide
- if you are under 25 years old.
If you have distressing thoughts or experiences, or if you notice that you feel worse or develop new symptoms while you’re taking Lamictal:
➔ See a doctor as soon as possible or go to the nearest hospital for help.
You may find it helpful to tell a family member, caregiver or close friend that you can become depressed or have significant changes in mood, and ask them to read this leaflet. You might ask them to tell you if they are worried about your depression or other changes in your behaviour.
A small number of people being treated with anti-epileptics such as Lamictal have also had thoughts of harming or killing
themselves. If at any time you have these thoughts, immediately contact your doctor.
If you’re taking Lamictal for epilepsy
The seizures in some types of epilepsy may occasionally become worse or happen more often while you’re taking Lamictal. Some patients may experience severe seizures, which may cause serious health problems. If your seizures happen more often or if you experience a severe seizure while you’re taking Lamictal: ➔ See a doctor as soon as possible.
Lamictal should not be given to people aged under 18 years to treat bipolar disorder. Medicines to treat depression and other mental health problems increase the risk of suicidal thoughts and behaviour in children and adolescents aged under 18 years. Other medicines and Lamictal
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines including herbal medicines or other medicines bought without a prescription. It is important to tell your doctor or pharmacist if you are taking any other medicines for epilepsy at the same time as lamotrigine if you are pregnant, think you may be pregnant, or are planning to have a baby (see also the information in section 2 on pregnancy and breast-feeding).
Your doctor needs to know if you are taking other medicines to treat epilepsy or mental health problems. This is to make sure you take the correct dose of Lamictal. These medicines include:
oxcarbazepine, felbamate, gabapentin, levetiracetam,
pregabalin, topiramate or zonisamide, used to treat epilepsy
lithium, olanzapine or aripiprazole used to treat mental
health problems
bupropion, used to treat mental health problems or to stop
smoking
- paracetamol, used to treat pain and fever
➔ Tell your doctor if you are taking any of these. Some medicines interact with Lamictal or make it more likely that people will have side effects. These include:
- valproate, used to treat epilepsy and mental health problems
carbamazepine, used to treat epilepsy and mental health
problems
phenytoin, primidone or phenobarbitone, used to treat
epilepsy
- risperidone, used to treat mental health problems
- rifampicin, which is an antibiotic
medicines used to treat Human Immunodeficiency
Virus (HIV) infection (a combination of lopinavir and ritonavir or atazanavir and ritonavir)
oestrogen-containing products, including hormonal
contraceptives, such as the Pill (see below) and hormone replacement therapy (HRT).
➔ Tell your doctor if you are taking any of these or if you
start or stop taking any.
Hormonal contraceptives (such as the Pill) can affect the way Lamictal works
Your doctor may recommend that you use a particular type of hormonal contraceptive or another method of contraception, such as condoms, a cap or coil. If you are using a hormonal contraceptive like the Pill, your doctor may take samples of your blood to check the level of Lamictal. If you are using a hormonal contraceptive or if you plan to start using one: ➔ Talk to your doctor, who will discuss suitable methods
of contraception with you.
Lamictal can also affect the way hormonal contraceptives work, although it’s unlikely to make them less effective. If you are using a hormonal contraceptive and you notice any changes in your menstrual pattern, such as breakthrough bleeding or spotting between periods:
➔ Tell your doctor. These may be signs that Lamictal is
affecting the way your contraceptive is working. HRT can affect the way Lamictal works
If you are using oestrogen-containing hormone replacement therapy (HRT), your doctor may take samples of your blood to check the level of Lamictal.
Pregnancy and breast-feeding
➔ If you are pregnant, or think you may be pregnant, you must tell your doctor straight away and discuss possible risks the epilepsy medicine you are taking might pose to your unborn baby.
➔ If you are planning to become pregnant you should discuss your epilepsy treatment with your doctor as early as possible before you become pregnant.
- You should not stop treatment without discussing this with your doctor. This is particularly important if you have epilepsy.
- Pregnancy may alter the effectiveness of Lamictal, so you may need blood tests and your dose of Lamictal may be adjusted.
- Studies of women who took lamotrigine at usual doses while they were pregnant have not shown an increased risk of physical birth abnormalities.
- The risk of physical birth abnormalities may increase when higher doses of epilepsy medicines are taken or more than one epilepsy medicine is used at the same time. Where possible, your doctor will consider using one epilepsy medicine at the lowest effective dose to control your epilepsy.
- Your doctor may advise you to take folic acid supplements if you’re planning to become pregnant and while you’re pregnant.
➔ If you are breast-feeding or planning to breast-feed ask your doctor or pharmacist for advice before taking this medicine. The active ingredient of Lamictal passes into breast milk and may affect your baby. Your doctor will discuss the risks and benefits of breast-feeding while you’re taking Lamictal and will check your baby from time to time, whether drowsiness, rash or poor weight gain occurs, if you decide to breast-feed. Inform your doctor if you observe any of these symptoms in your baby. Driving and using machines
Lamictal can cause dizziness and double vision.
➔ Don’t drive or use machines unless you are sure you’re not affected.
If you have epilepsy, talk to your doctor about driving and using machines.
25 mg, 50 mg, 100 mg and 200 mg tablets
lamotrigine
200004410 front page 1665
1665
Manufacturing Site Number:
200004410
Manufacturing Site(s):
Delpharm_Poznan_POLAND
DRW_L_020_01_FD
Product Market Trade Name:
LAMICTAL
Approving Market(s):
United Kingdom-GBR
Material Spec: (Do NOT include version number):
N/A
N/A
Colour Standard Reference:
N/A
Material Type:
N/A N/A
8.0pt
8.0pt
Leading:
8.2pt
Horizontal Scale:
90%
Microtext:
N
1
0
Additional Info (1):
N/A
Additional Info (2):
N/A
Additional Info (3):
N/A
200 mm Measuring Bar
Artwork copyright is the property of the GSK Group of Companies. All suppliers providing a service to GSK for printed components of any description must ensure that they have a licence for all fonts / software used in conjunction with GSK artwork. The distribution and use of fonts / software without a licence constitutes an intellectual property infringement. GSK will not accept any liability for the breach of third party intellectual property rights by printed component suppliers. The GSK certification / audit process requires suppliers to declare that they do not use unlicensed fonts / software and may require the supplier to produce evidence of such licence to GSK.
Production Site:
Delpharm_Poznan_POLAND
Leaflet - flat dimensions (width x height):
148 x 608 mm
folded dimensions (width x height):
N/A
Foil / Laminate - dimensions (width):
N/A
random repeats:
N/A
Carton - dimensions (width x height x depth):
N/A
Tube - dimensions (Ø, length):
N/A
Label - dimensions (width x height):
N/A
200003406
Point of Sale Code Number:
N/A
IMPORTANT GSK LOC is responsible to
and complete.
pre-press suitability.
GSK Market is responsible to advise SDC when changes required impact the following:
Formulation Tablet embossing Storage conditions
Shelf Life
NOTE TO MARKET Local approvers must ensure that trade mark and copyright statements included in the brief
comply with guidance provided by Legal: Global Trade Marks.
3 How to take Lamictal
Always take this medicine exactly as your doctor or
pharmacist has told you. Check with your doctor or
pharmacist if you are not sure.
How much Lamictal to take
It may take a while to find the best dose of Lamictal
for you. The dose you take will depend on:
- your age
whether you are taking Lamictal with other
medicines
- whether you have any kidney or liver problems.
Your doctor will prescribe a low dose to start and
gradually increase the dose over a few weeks until
you reach a dose that works for you (called the
effective dose). Never take more Lamictal than your
doctor tells you to.
The usual effective dose of Lamictal for adults and
children aged 13 years or over is between 100 mg
and 400 mg each day.
For children aged 2 to 12 years, the effective dose
depends on their body weight - usually, it’s between
1 mg and 15 mg for each kilogram of the child’s
weight, up to a maximum maintenance dose of
200 mg daily.
Lamictal is not recommended for children aged under 2 years.
How to take your dose of Lamictal
Take your dose of Lamictal once or twice a day, as your doctor advises. It can be taken with or without food.
Your doctor may also advise you to start or stop taking other medicines, depending on what condition you’re being treated for and the way you respond to treatment.
Swallow your tablets whole. Don’t break, chew
or crush them.
Always take the full dose that your doctor has
prescribed. Never take only part of a tablet. If you take more Lamictal than you should
➔ Contact a doctor or nearest hospital emergency
department immediately. If possible, show them the Lamictal packet.
If you take too much Lamictal you may be more likely to have serious side effects which may be fatal.
Someone who has taken too much Lamictal may have any of these symptoms:
- rapid, uncontrollable eye movements (nystagmus)
clumsiness and lack of co-ordination, affecting
their balance (ataxia)
- heart rhythm changes (detected usually on ECG)
- loss of consciousness, fits (convulsions) or coma. If you forget to take a single dose of Lamictal
➔ Don’t take extra tablets to make up for a missed dose. Just take your next dose at the usual time. In case you forget to take multiple doses of Lamictal
➔ Ask your doctor for advice on how to start taking
it again. It’s important that you do this.
Don’t stop taking Lamictal without advice
Lamictal must be taken for as long as your doctor recommends. Don’t stop unless your doctor advises you to.
If you’re taking Lamictal for epilepsy
To stop taking Lamictal, it is important that the dose is reduced gradually, over about 2 weeks. If you suddenly stop taking Lamictal, your epilepsy may come back or get worse.
If you’re taking Lamictal for bipolar disorder
Lamictal may take some time to work, so you are unlikely to feel better straight away. If you stop taking Lamictal, your dose will not need to be reduced gradually. But you should still talk to your doctor first, if you want to stop taking Lamictal.
4 Possible side effects
Like all medicines, this medicine can cause side effects, but not everyone gets them.
Potentially life-threatening reactions: get a doctor’s help straight away
A small number of people taking Lamictal get an allergic reaction or potentially life-threatening skin reaction, which may develop into more serious problems if they are not treated.
These symptoms are more likely to happen during the first few months of treatment with Lamictal, especially if the starting dose is too high or if the dose is increased too quickly or if Lamictal is taken with another medicine called valproate. Some of the symptoms are more common in children, so parents should be especially careful to watch out for them.
Symptoms of these reactions include:
skin rashes or redness, which may develop into
serious or sometimes life-threatening skin reactions including rash with target lesions (Erythema multiforme), widespread rash with blisters and peeling skin, particularly occurring around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), extensive peeling of the skin (more than 30% of the body surface - toxic epidermal necrolysis) or extended rashes with liver, blood and other body organs involvement (Drug Reaction with Eosinophilia and Systemic Symptoms which is also known as DRESS hypersensitivity syndrome)
- ulcers in the mouth, throat, nose or genitals
a sore mouth or red or swollen eyes
(conjunctivitis)
a high temperature (fever), flu-like symptoms or
drowsiness
swelling around your face or swollen glands in
your neck, armpit or groin
unexpected bleeding or bruising, or the fingers
turning blue
a sore throat or more infections (such as colds)
than usual
increased levels of liver enzymes seen in blood
tests
an increase in a type of white blood cell
(eosinophils)
- enlarged lymph nodes
involvement of the organs of the body including
liver and kidneys.
In many cases, these symptoms will be signs of less serious side effects but you must be aware that they are potentially life-threatening and can develop into more serious problems, such as organ failure, if they are not treated. If you notice any of these symptoms: ➔ Contact a doctor immediately. Your doctor may
decide to carry out tests on your liver, kidneys or blood and may tell you to stop taking Lamictal.
In case you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis your doctor will tell you that you must never use lamotrigine again.
Haemophagocytic lymphohistiocytosis (HLH) (see section 2: What you need to know before you take Lamictal).
Very common side effects
These may affect more than 1 in 10 people:
- headache
- skin rash.
Common side effects
These may affect up to 1 in 10 people:
- aggression or irritability
- feeling sleepy or drowsy
- feeling dizzy
- shaking or tremors
- difficulty in sleeping (insomnia)
- feeling agitated
- diarrhoea
- dry mouth
- feeling sick (nausea) or being sick (vomiting)
- feeling tired
- pain in your back or joints, or elsewhere. Uncommon side effects
These may affect up to 1 in 100 people:
- clumsiness and lack of co-ordination (ataxia)
- double vision or blurred vision
- unusual hair loss or thinning (alopecia)
skin rash or sunburn after exposure to sun or
artificial light (photosensitivity).
Rare side effects
These may affect up to 1 in 1 000 people:
skin reaction that causes red spots or patches on
the skin, that may look like a target or “bulls-eye” with a dark red centre surrounded by paler red rings (erythema multiforme)
a life-threatening skin reaction (Stevens-Johnson
syndrome): (see also the information at the beginning of section 4)
a group of symptoms together including: fever,
nausea, vomiting, headache, stiff neck and extreme sensitivity to bright light. This may be caused by an inflammation of the membranes that cover the brain and spinal cord (meningitis). These symptoms usually disappear once treatment is stopped however if the symptoms continue or get worse contact your doctor
- rapid, uncontrollable eye movements (nystagmus)
itchy eyes, with discharge and crusty eyelids
(conjunctivitis).
Very rare side effects
These may affect up to 1 in 10 000 people:
a life-threatening skin reaction (toxic epidermal
necrolysis): see also the information at the beginning of section 4
Drug Reaction with Eosinophilia and Systemic
Symptoms (DRESS): (see also the information at the beginning of section 4)
a high temperature (fever): (see also the
information at the beginning of section 4)
swelling around the face (oedema) or swollen
glands in the neck, armpit or groin
(lymphadenopathy): (see also the information at the beginning of section 4)
changes in liver function, which will show up in
blood tests, or liver failure: (see also the information at the beginning of section 4)
a serious disorder of blood clotting, which can
cause unexpected bleeding or bruising (disseminated intravascular coagulation): (see also the information at the beginning of section 4)
haemophagocytic lymphohistiocytosis (HLH)
(see section 2: What you need to know before you take Lamictal)
changes which may show up in blood tests -
including reduced numbers of red blood cells
(anaemia), reduced numbers of white blood cells (leucopenia, neutropenia, agranulocytosis), reduced numbers of platelets (thrombocytopenia), reduced numbers of all these types of cell (pancytopenia) and a disorder of the bone marrow called aplastic anaemia
hallucinations (‘seeing’ or ‘hearing’ things that
aren’t really there)
- confusion
- feeling ‘wobbly’ or unsteady when you move about
uncontrollable repeated body movements
and/or sounds or words (tics), uncontrollable muscle spasms affecting the eyes, head and torso (choreoathetosis) or other unusual body movements such as jerking, shaking or stiffness
in people who already have epilepsy, seizures
happening more often
in people who already have Parkinson’s disease,
worsening of the symptoms.
lupus-like reaction (symptoms may include:
back or joint pain which sometimes may be accompanied by fever and/or general ill health). Other side effects
Other side effects have occurred in a small number of people but their exact frequency is unknown:
There have been reports of bone disorders including
osteopenia and osteoporosis (thinning of the bone) and fractures. Check with your doctor or pharmacist if you are on long-term anti-epileptic medication, have a history of osteoporosis or take steroids.
inflammation of the kidney (tubulointerstitial
nephritis), or inflammation of both the kidney and the eye (tubulointerstitial nephritis and uveitis syndrome)
- Nightmares
Lower immunity because of lower levels of
antibodies called immunoglobulins in the blood which help protect against infection.
Red nodules or patches on the skin
(pseudolymphoma).
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5 How to store Lamictal
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date shown on the blisters or carton. The expiry date refers to the last day of that month.
Lamictal does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. This will help protect the environment.
6 Contents of the pack
and other information What Lamictal tablets contain
The active substance is lamotrigine. Each tablet contains 25 mg, 50 mg, 100 mg or 200 mg lamotrigine.
The other ingredients are: lactose monohydrate, microcrystalline cellulose, povidone K30, sodium starch glycolate (Type A), iron oxide yellow (E172) and magnesium stearate.
What Lamictal tablets look like and contents of the pack
Lamictal tablets (all strengths) are square with rounded corners and pale, yellowish brown in colour. Not all listed pack sizes may be marketed. Lamictal 25 mg tablets are marked ‘GSEC7’ on one side and ‘25’ on the other. Each pack contains blisters of 14, 21, 28, 30, 42, 50, 56 or 100 tablets. Lamictal 50 mg tablets are marked ‘GSEE1’ on one side and ‘50’ on the other. Each pack contains blisters of 14, 28, 30, 42, 56, 90, 98 or 100 tablets. Lamictal 100 mg tablets are marked ‘GSEE5’ on one side and ‘100’ on the other. Each pack contains blisters of 28, 30, 42, 50, 56, 60, 90, 98 or 100 tablets. Lamictal 200 mg tablets are marked ‘GSEE7’ on one side and ‘200’ on the other. Each pack contains blisters of 28, 30, 42, 56 or 100 tablets.
Marketing authorisation holder and manufacturer
Marketing Authorisation Holder:
The Wellcome Foundation Ltd., 79 New Oxford Street, London, WC1A 1DG, United Kingdom
Manufacturer: Delpharm Poznań Spółka Akcyjna, Ul. Grunwaldzka 189, 60-322 Poznań, Poland This leaflet was last revised in June 2026
Trademarks are owned by or licensed to the GSK group of companies
© 2026 GSK group of companies or its licensor
200004410 Important information about some of
the ingredients of Lamictal
Lamictal tablets contain small amounts of a sugar
called lactose. If you have been told by your doctor
that you have an intolerance to some sugars, contact
your doctor before taking this medicinal product.
Lamictal tablets contains less than 1 mmol sodium
(23 mg) per tablet, that is to say essentially
‘sodium-free’.
back Page
Manufacturing Site Number:
200004410
Manufacturing Site(s):
Delpharm_Poznan_POLAND
DRW_L_020_01_FD
Product Market Trade Name:
LAMICTAL
Approving Market(s):
United Kingdom-GBR
Material Spec: (Do NOT include version number):
N/A
N/A
Colour Standard Reference:
N/A
Material Type:
N/A N/A
8.0pt
8.0pt
Leading:
8.2pt
Horizontal Scale:
90%
Microtext:
N
1
0
Additional Info (1):
N/A
Additional Info (2):
N/A
Additional Info (3):
N/A
200 mm Measuring Bar
Artwork copyright is the property of the GSK Group of Companies. All suppliers providing a service to GSK for printed components of any description must ensure that they have a licence for all fonts / software used in conjunction with GSK artwork. The distribution and use of fonts / software without a licence constitutes an intellectual property infringement. GSK will not accept any liability for the breach of third party intellectual property rights by printed component suppliers. The GSK certification / audit process requires suppliers to declare that they do not use unlicensed fonts / software and may require the supplier to produce evidence of such licence to GSK.
Production Site:
Delpharm_Poznan_POLAND
Leaflet - flat dimensions (width x height):
148 x 608 mm
folded dimensions (width x height):
N/A
Foil / Laminate - dimensions (width):
N/A
random repeats:
N/A
Carton - dimensions (width x height x depth):
N/A
Tube - dimensions (Ø, length):
N/A
Label - dimensions (width x height):
N/A
200003406
Point of Sale Code Number:
N/A
IMPORTANT
GSK LOC is responsible to approve the change
site technical requirements and pre-press suitability.
GSK Market is responsible
to advise SDC when changes required impact the following:
Formulation
Tablet embossing
Storage conditions
Shelf Life
NOTE TO MARKET
Local approvers must ensure that trade mark and copyright statements included in the brief comply with guidance provided by
Legal: Global Trade Marks.